Chinese biopharma firms are actively pursuing Hong Kong IPOs, following the strong debut of Duality Biotherapeutics earlier this month.
Chinese Biopharma Firms Chase Hong Kong IPO, After Duality’s Sizzling Debut
Where Today's News Shapes Tomorrow
